Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors

Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors Selective COX-2 inhibitors. Part 1: Synthesis and biological evaluation of phenylazobenzenesulfonamides Synthesis, Inhibitory Activity, and In Silico Modeling of Selective COX-1 Inhibitors with a Quinazoline Core Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Substituted Di-tert-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 2. 1,3,4- and 1,2,4-Thiadiazole Series Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3- c ]pyrazol-4(1 H )-ones as potential cyclooxygenase-2 (COX-2) inhibitors Synthesis and biological evaluation of 1,3,4-triaryl-3-pyrrolin-2-ones, a new class of selective cyclooxygenase-2 inhibitors New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors Naphthalene derivatives: A new series of selective cyclooxygenase-2 inhibitors